These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7537105)

  • 21. Antithrombotic effect of crotalin, a platelet membrane glycoprotein Ib antagonist from venom of Crotalus atrox.
    Chang MC; Lin HK; Peng HC; Huang TF
    Blood; 1998 Mar; 91(5):1582-9. PubMed ID: 9473223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction.
    Mazurov AV; Vinogradov DV; Vlasik TN; Repin VS; Booth WJ; Berndt MC
    Thromb Res; 1991 Jun; 62(6):673-84. PubMed ID: 1718052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib.
    Fujimura Y; Usami Y; Titani K; Niinomi K; Nishio K; Takase T; Yoshioka A; Fukui H
    Blood; 1991 Jan; 77(1):113-20. PubMed ID: 1984791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
    Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP
    Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Fc receptor gamma-chain in platelet glycoprotein Ib-mediated signaling.
    Wu Y; Suzuki-Inoue K; Satoh K; Asazuma N; Yatomi Y; Berndt MC; Ozaki Y
    Blood; 2001 Jun; 97(12):3836-45. PubMed ID: 11389024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
    Ward CM; Andrews RK; Smith AI; Berndt MC
    Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for p38 MAP kinase in platelet activation by von Willebrand factor.
    Canobbio I; Reineri S; Sinigaglia F; Balduini C; Torti M
    Thromb Haemost; 2004 Jan; 91(1):102-10. PubMed ID: 14691575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
    Gjønnaess E; Solum NO; Brosstad F
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.
    Rabinowitz I; Tuley EA; Mancuso DJ; Randi AM; Firkin BG; Howard MA; Sadler JE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9846-9. PubMed ID: 1409710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.
    De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.
    Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D
    Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions.
    Dong JF; Berndt MC; Schade A; McIntire LV; Andrews RK; López JA
    Blood; 2001 Jan; 97(1):162-8. PubMed ID: 11133756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adhesion of blood platelets is inhibited by VCL, a recombinant fragment (leucine504 to lysine728) of von Willebrand factor.
    Sixma JJ; Ijsseldijk MJ; Hindriks G; van Zanten GH; Gorecki M; Panet A; Garfinkel LI; de Groot PG
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):64-71. PubMed ID: 8548428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet glycoprotein Ib monoclonal antibody (OP-F1) totally abolishes ristocetin-induced von Willebrand factor binding, but has minimal effect on the botrocetin-induced binding.
    Nishio K; Fujimura Y; Nishida S; Takeda I; Yoshioka A; Fukui H; Tomiyama Y; Kurata Y
    Haemostasis; 1991; 21(6):353-9. PubMed ID: 1823880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets.
    Phillips MD; Moake JL; Nolasco L; Turner N
    Blood; 1988 Dec; 72(6):1898-903. PubMed ID: 3264193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species.
    Zurbano MJ; Escolar G; Heras M; Ordinas A; Castillo R
    Haematologica; 2000 May; 85(5):514-9. PubMed ID: 10800169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botrocetin/VWF-induced signaling through GPIb-IX-V produces TxA2 in an alphaIIbbeta3- and aggregation-independent manner.
    Liu J; Pestina TI; Berndt MC; Jackson CW; Gartner TK
    Blood; 2005 Oct; 106(8):2750-6. PubMed ID: 15985541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.
    De Marco L; Girolami A; Russell S; Ruggeri ZM
    J Clin Invest; 1985 Apr; 75(4):1198-203. PubMed ID: 3157702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma.
    Casonato A; De Marco L; Mazzucato M; De Angelis V; De Roia D; Fabris F; Ruggeri ZM; Girolami A
    Blood; 1989 Nov; 74(6):2028-33. PubMed ID: 2804346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ristocetin-mediated interaction of human von Willebrand factor with platelet glycoprotein lb evokes a transient calcium signal: observations with Fura-PE3.
    Milner EP; Zheng Q; Kermode JC
    J Lab Clin Med; 1998 Jan; 131(1):49-62. PubMed ID: 9452127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.